Whitepaper

#Antibodies #Antibody binding #Flow Cytometry #T cell activation #Whitepaper

High throughput, multi-parametric analysis accelerates antibody discovery workflows

In this whitepaper, we present the unique benefits of the high-throughput iQue®Advanced Flow Cytometry Platform, combined with built-in, visual-based iQue Forecyt®software, in the antibody discovery workflow. Learn analysis details of: Antibody Binding Antibody Internalisation and Viability ADCP Measurement in Adherent Cells ADCP Measurement in Suspension Cells Quantification of NK Cell-Mediated… Read More

#Intelligence #Resources

Lightning
#Electroporation #Gene delivery #Whitepaper

Whitepaper: Electroporation Made Easy for Hard-to-Transfect Cells

Electroporation is a highly effective, versatile technique for the delivery of molecular cargo to many different cell types and tissues of biomedical relevance. Despite its efficacy, electroporation is under-utilised because of the perceived initial up-front cost in purchasing an electroporator and its association with high cytotoxicity. Download… Read More

#News

#Electroporation #Gene delivery #Whitepaper

Electroporation Made Easy for Hard-to-Transfect Cells

Download the latest Mirus Bio whitepaper to learn about: The differences between gene delivery methods (electroporation, chemical transfection and viral transduction). Optimising electroporation with the Ingenio(R) EZporator(R) Electroporation System. Electroporate multiple cell types with high efficiency and viability. Deliver different molecular cargo. Read More

#Intelligence #Resources

#Assay #Whitepaper

Learn about viral titer and quality in this whitepaper

This whitepaper brought to you by Mirus Bio details the multiple approaches developers can use to verify the quality and functionality of viral assays. Download the latest Mirus Bio whitepaper to learn about: Methods to characterize lentivirus and adeno-associated virus Differences between physical and functional assays of virus How to… Read More

#News

#Drug discovery #Innovation #Whitepaper

Whitepaper: Maximising outsourcing models beyond time and cost

In this whitepaper, we will expand on key factors – cost, time, and innovation – and illustrate how integrating these factors will minimise the challenges and ensure success in outsourcing drug discovery. Learn about: Opportunities, options, and outsourcing of drug discovery programs Hidden costs vs. hidden value Impact on… Read More

#News

#Clinical trials #CRO #Whitepaper

Whitepaper: How to reduce your clinical study budget by 55%

Learn how to reduce your clinical study budget by 45-55% in Central and Eastern Europe by downloading this Whitepaper by Research Professionals CRO. This whitepaper identifies the most significant cost elements of a typical clinical study budget and breaks it… Read More

#News

#Cancer research #Immunology / Virology & Vaccines #Whitepaper

Cancer vaccine white paper from Frost and Sullivan industry experts

In this white paper, brought to you by BioRad, hear from leading industry experts in the emerging field of cancer vaccines. The experts discuss: Challenges related to antigen and adjuvant selection Vaccine design Immune response improvement Future treatment options Download the white paper here. Read More

#News

#Cytokines #In vitro #In vivo #Research study #Whitepaper

White Paper: A new way to study cytokine release syndrome

An in vivo CRS Evaluation Study in humanised mouse models can deliver fast, reproducible, and translatable data about drug safety in just two weeks. A humanised mouse platform offers the unique ability to preclinically analyse a fully systemic response that involves human immune cells and surrounding tissues. Furthermore, the platform… Read More

#News #Trending News

#Whitepaper

Whitepaper: Process optimisation in antibody discovery workflows

Discover how process optimisation utilising automated synthetic biology solutions can remove the antibody sequence cloning bottleneck that divides high-content lead identification and downstream high throughput characterisation. If your work involves antibody discovery or process improvement in recombinant cloning don’t miss this whitepaper illustrating how Codex DNA’s synthetic biology solutions can… Read More

#News #Trending News

#Bioactive proteins #Cell culture #Cytokines #Whitepaper

Discover future ready bioactive proteins: whitepaper

From basic to translational research and clinical applications, cell culture is an essential technique that underpins the generation of promising cell and gene therapies, says Abcam. Since the quality of cytokines and growth factors can significantly influence the properties and function of cultured cells, these bioactive proteins must be produced… Read More

#News

#Pharmaceuticals #Whitepaper

Whitepaper examines balances for analytical purposes 

European Pharmacopoeia (Ph. Eur.) General Chapter 2.1.7 Balances for Analytical Purposes was published in July 2021. Compliance with this chapter by January 1, 2022 is mandatory for any pharmaceutical company who manufactures in, or exports into, the European market.   Balances for Analytical Purposes aims to ensure quality control of… Read More

#News

#Biopharmaceutical #Molecular Biology #Whitepaper

What makes a great BioELN?

In this latest DDW whitepaper, brought to you by PerkinElmer Informatics, John Conway, is Chief Visioneer Officer at 20/15 Visioneers, tackles defining “What Makes a Great BioELN” in this thoughtful and informative industry perspective. The whitepaper covers the six high-level workflows a great BioELN must include; what the team personas… Read More

#News

#Lipidomics #Lipids #Whitepaper

Developing better treatments using lipids

Scientific and technological advancements are making it easier to understand the causes of and physiological processes of diseases and how molecular and biochemical aspects of lipids play a role. Due to its promising application for identifying and quantifying lipids as biomarkers of disease, lipidomics research has advanced considerably in recent… Read More

#News

#Biotechnology #Drug discovery #High throughput screening #Whitepaper

High-throughput screening for small molecule drug discovery

High-throughput screening remains one of the most powerful, unbiased approaches for small molecule drug discovery. In this whitepaper, “Disrupting Drug Discovery From Assay Development to Lead Compound”, SAMDI Tech CSO, Zack Gurard-Levin, discusses the important aspects to consider when choosing the right methodology for drug discovery. The whitepaper covers traditional… Read More

#News

#Data #Drug discovery #Drug screening #Screening #Whitepaper

Expertise on analysis of targeted protein degrader compounds

Small molecule drug discovery is expanding beyond traditional strategies focused on identifying compounds that inhibit or block the activity of proteins that cause disease, says Promega. A newer approach to small molecule drug discovery is to selectively target proteins for removal from the cell using degrader compounds, focussing on identifying… Read More

#News

#Drug discovery #High throughput screening #Whitepaper

Improve the drug discovery tool box

Making good decisions in the drug discovery process requires software to effectively manage the size and complexity of multiparametric datasets. Companies that most quickly and accurately identify key drug discovery parameters will win the race to identify the most appropriate targets and develop medicines to affect them. PerkinElmer has produced… Read More

#News